First Time Loading...

Starpharma Holdings Ltd
ASX:SPL

Watchlist Manager
Starpharma Holdings Ltd Logo
Starpharma Holdings Ltd
ASX:SPL
Watchlist
Price: 0.12 AUD Market Closed
Updated: May 5, 2024

Wall Street
Price Targets

SPL Price Targets Summary
Starpharma Holdings Ltd

There are no price targets for SPL.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Starpharma Holdings Ltd Competitors:
Price Targets
001630
Chongkundang Holdings Corp
15% Upside
EAH
ECO Animal Health Group PLC
86% Upside
ELAN
Elanco Animal Health Inc
34% Upside
005500
Samjin Pharmaceutical Co Ltd
60% Upside
PER
Percheron Therapeutics Ltd
231% Upside
1795
Lotus Pharmaceutical Co Ltd
44% Upside
063160
CKD Bio Corp
13% Upside
000908
Hunan Jingfeng Pharmaceutical Co Ltd
640% Upside

Revenue
Forecast

Revenue Estimate
Starpharma Holdings Ltd

For the last 8 years the compound annual growth rate for Starpharma Holdings Ltd's revenue is 12%. The projected CAGR for the next 2 years is 6%.

12%
Past Growth
6%
Estimated Growth
Estimates Accuracy
-62%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Starpharma Holdings Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
17%
Average Beat

Net Income
Forecast

Net Income Estimate
Starpharma Holdings Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
4%
Average Beat

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is SPL's stock price target?
Not Available

SPL doesn't have any price targets made by Wall Street professionals.

What is Starpharma Holdings Ltd's Revenue forecast?
Projected CAGR
6%

For the last 8 years the compound annual growth rate for Starpharma Holdings Ltd's revenue is 12%. The projected CAGR for the next 2 years is 6%.